Daptomycin Injection Products
|
|
Minimum Inhibitory |
Disk Diffusion |
||||
|---|---|---|---|---|---|---|
|
Pathogen |
S |
I |
R |
S |
I |
R |
|
Enterococcus faecalis (including vancomycin-resistant isolates)* |
≤2 |
4 |
≥8 |
- |
- |
- |
|
Staphylococcus aureus (including methicillin-resistant isolates) |
M100 standard is recognized |
- |
- |
- |
||
|
Streptococcus pyogenes |
M100 standard is recognized |
- |
- |
- |
||
|
Streptococcus agalactiae |
M100 standard is recognized |
- |
- |
- |
||
|
Streptococcus dysgalactiae |
M100 standard is recognized |
- |
- |
- |
||
S = Susceptible; I = Intermediate; R = Resistant
* Susceptibility test interpretive criteria are based on the daptomycin dose of 4 mg/kg once every 24 hours
Exception to the recognized standard of CLSI M100
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Enterococcus faecium